Mankind Pharma (MANKIND) Share News & Alerts

Stock Picks Today: Bullish On Adani Ports; Hindalco, JSW Steel, Mankind Pharma; CarTrade On Brokerage Radar

▲ Bullish +1.55%

Jefferies maintained a strong Buy rating with a target price of Rs 3,000, noting volume recovery in acute therapies and international export potential from Bharat Serums. This positive fundamental confirmation helps clear recent volume consolidation for a fresh upward swing.

​Ipca Laboratories among 5 stocks showing bullish RSI upswing

▲ Bullish +2.37%

An RSI move above the 50 centerline reflects improving price strength, which often attracts momentum traders looking for a positional long entry.

Mankind Pharma Ltd eases for fifth straight session

▼ Bearish +5.94%

Mankind Pharma is experiencing a routine short-term technical pullback, closing lower for five straight sessions as traders take profits following its recent earnings. The drop represents a minor contraction within its structural band, finding support near its key short-term moving averages. This technical easing is expected to stabilize over a 1-2 week swing timeframe without altering the stock's medium-term outlook.

Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sector

▼ Bearish +3.6%

The stock was given an 'Underperform' rating by Bernstein, reflecting concerns over its growth valuation versus upcoming industry catalysts. This negative assessment is expected to act as a near-term headwind, leading to bearish or underperforming price action.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 21 May 2026

▲ Bullish +2.1%

Mankind Pharma is recommended based on technical breakout and positive momentum signals. The stock exhibits potential for minor bullish swing upside over a multi-day timeframe as it clears near-term resistance zones.

Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?

▲ Bullish +1.22%

Mankind Pharma is directly benefiting from a 32% year-on-year surge in Q4 net profits and robust domestic revenue growth. Supported by a sector-wide breakout and defensive capital rotation, this strong fundamentally backed momentum positions the stock for a bullish continuation over a multi-week swing horizon.

Stocks to watch: Lenskart, BPCL, Hindalco among 10 shares in focus today; check list here

▲ Bullish +5.84%

Mankind Pharma delivered a robust Q4 performance with a 30% year-on-year surge in net profit to ₹554 crore, driven by strong domestic demand for chronic therapies and improved sales execution. This strong fundamental beat is highly supportive of a bullish multi-day swing trade trajectory.

Mankind Pharma Q4 Result: Net Profit Rises 32%, Margins Expand

▲ Bullish +5.84%

Mankind Pharma's stock is directly impacted by a strong Q4 performance showing a 32% profit growth and major EBITDA margin expansion from 22.2% to 27%. This operational beat acts as a positive fundamental trigger likely to drive a bullish price breakout in swing and positional timeframes over the next few weeks.

Q4 Results Live Updates: Eureka Forbes Profit Flat; BEL, BPCL To Report Earnings

▲ Bullish +4.72%

The pharma major is expected to trade with elevated volatility over the short-term swing horizon as market participants position for its fourth-quarter earnings release. Actual outcomes against institutional expectations will clear up its directional trend over the multi-day window.

Q4 results 2026: Bharat Electronics to BPCL among companies to declare Q4 results today; check full list here

▲ Bullish +5.71%

Mankind Pharma's Q4 earnings will act as a major catalyst for the stock, where margin expansion and domestic sales growth will determine if the current bullish trend sustains.

Stocks to watch: BEL, IOC, Lupin among 10 shares in focus today; check list here

▲ Bullish +5.71%

Mankind Pharma is reporting its Q4 financial results today, driving sharp intraday and short-term directional momentum based on operational performance and margin outlook guidance.

Q4 Results Next Week: BEL, ITC, BPCL, LIC, Ola Electric, Bikaji Foods, Lenskart, Honasa Consumer And More

▲ Bullish +5.4%

Mankind Pharma's upcoming results will showcase its domestic formulation growth and integration efficiencies. Expected to cause a multi-day price impact based on its future earnings guidance.

Zydus Lifesciences Ltd soars 2.1%

▲ Bullish +5.4%

Rising for a third consecutive session with a 19% gain over the past month, the stock is benefiting from technical momentum and an upcoming board meeting on May 19 for audited results. The price action suggests a sustained positional uptrend as it nears its 52-week high of ₹2716.

Medicine Availability Likely To Be Impacted On May 20 As Over 12 Lakh Chemists Plan Shutdown — What We Know

▼ Bearish —

Stock Picks Today: Marico, M&M, Coforge, L&T, Hero Moto And More On Brokerages' Radar

▲ Bullish +6.79%

Identified as a technical pick for a target of ₹2,468, the stock is benefiting from a broader sector rotation into defensive pharma names amid market volatility.

Mankind Pharma to CG Power - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment

▲ Bullish +6.79%

The stock has broken out of a falling channel consolidation with short covering and lagging indicators confirming a shift in momentum. Analyst targets suggest a test of overhead resistance levels near 2,300 on a short-term swing basis.